HK18496A - Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetamido)-3-vinyl-3-cephem-4-carboxzlic acid (synisomer) - Google Patents

Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetamido)-3-vinyl-3-cephem-4-carboxzlic acid (synisomer)

Info

Publication number
HK18496A
HK18496A HK18496A HK18496A HK18496A HK 18496 A HK18496 A HK 18496A HK 18496 A HK18496 A HK 18496A HK 18496 A HK18496 A HK 18496A HK 18496 A HK18496 A HK 18496A
Authority
HK
Hong Kong
Prior art keywords
aminothiazol
cephem
vinyl
acid
carboxzlic
Prior art date
Application number
HK18496A
Other languages
English (en)
Inventor
Takao Takaya
Fumiyuki Shirai
Hitoshi Nakamura
Yasunobu Inaba
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16519432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK18496(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of HK18496A publication Critical patent/HK18496A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18496A 1987-08-19 1996-02-01 Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetamido)-3-vinyl-3-cephem-4-carboxzlic acid (synisomer) HK18496A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20619987 1987-08-19

Publications (1)

Publication Number Publication Date
HK18496A true HK18496A (en) 1996-02-09

Family

ID=16519432

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18496A HK18496A (en) 1987-08-19 1996-02-01 Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetamido)-3-vinyl-3-cephem-4-carboxzlic acid (synisomer)

Country Status (11)

Country Link
US (1) US4935507A (de)
EP (1) EP0304019B1 (de)
KR (1) KR970008126B1 (de)
AT (1) ATE123221T1 (de)
AU (1) AU617347B2 (de)
CA (1) CA1297096C (de)
DE (1) DE3853901T2 (de)
ES (1) ES2072856T3 (de)
HK (1) HK18496A (de)
IE (1) IE67348B1 (de)
ZA (1) ZA885709B (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT405283B (de) * 1997-04-04 1999-06-25 Biochemie Gmbh Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
US6888124B1 (en) 1999-03-24 2005-05-03 Shell Oil Company Method to monitor internal parameters of electrical motor systems
US20050020561A1 (en) * 2001-04-17 2005-01-27 Yatendra Kumar Process for the preparation of cefpodoxime acid
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
KR20030018536A (ko) * 2001-08-30 2003-03-06 임득수 유리제품의 표면처리방법
US20050080255A1 (en) * 2001-12-13 2005-04-14 Yatendra Kumar Crystalline cefdinir potassium dihydrate
US7297800B2 (en) * 2001-12-27 2007-11-20 Ajinomoto Co., Inc. Process of producing glutamate derivatives
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
US6800756B2 (en) * 2002-05-03 2004-10-05 Orchid Chemicals And Pharmaceuticals, Ltd. Method for the preparation of ceftiofur sodium and its intermediates
WO2004016623A1 (en) * 2002-08-13 2004-02-26 Sandoz Ag A cefdinir intermediate
CN103525847A (zh) 2002-08-26 2014-01-22 味之素株式会社 新型醛缩酶和取代α-酮酸的制备方法
WO2004046154A1 (en) * 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
KR100723826B1 (ko) 2002-12-09 2007-06-04 아지노모토 가부시키가이샤 변이형 ｄ－아미노트랜스퍼라제 및 이를 사용하는 광학활성글루탐산 유도체의 제조방법
ITMI20022724A1 (it) * 2002-12-20 2004-06-21 Antibioticos Spa Sali cristallini del cefdinir.
AU2004206827A1 (en) 2003-01-14 2004-08-05 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
AU2004224045A1 (en) * 2003-03-24 2004-10-07 Sandoz Ag Novel crystal of 7-[2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetamido-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof
WO2004104010A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US20050137182A1 (en) * 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US7098329B2 (en) * 2003-06-19 2006-08-29 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of a cephalosporin antibiotic
US20050059818A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20050059819A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Cefdinir pyridine salt
US20050113355A1 (en) * 2003-09-12 2005-05-26 Duerst Richard W. Cefdinir pyridine salt
US20050131079A1 (en) * 2003-12-10 2005-06-16 Pujara Chetan P. Cefdinir oral suspension
US20080139528A1 (en) * 2003-12-10 2008-06-12 Pujara Chetan P Cefdinir oral suspension
US20060211676A1 (en) * 2004-03-16 2006-09-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060142563A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142261A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
WO2006018807A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
MX2007006018A (es) * 2004-11-30 2007-06-07 Astellas Pharma Inc Suspension farmaceutica oral novedosa de cristal de cefdinir.
GB2421024A (en) * 2004-12-07 2006-06-14 Sandoz Ag Cefdinir crystalline form C
WO2006117794A1 (en) * 2005-05-02 2006-11-09 Hetero Drugs Limited A novel crystalline form of cefdinir
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
US20070244315A1 (en) * 2005-10-31 2007-10-18 Kansal Vinod K Process for the preparation of cefdinir
WO2007053722A2 (en) * 2005-10-31 2007-05-10 Teva Pharmaceutical Industries Ltd. Crystalline form of cefdinir cesium salt
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
ITMI20071628A1 (it) 2007-08-06 2007-11-05 Acs Dobfar Spa Sintesi di 3-alchenilcefalosporine e nuovi intermedi utili ad esse correlati
CN101481383B (zh) * 2008-12-31 2012-01-11 杭州奥默医药技术有限公司 头孢地尼酸式复盐化合物及制备方法
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
EP2862569A1 (de) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Verfahren zur Behandlung von intrapulmonalen Infektionen
CN102643293A (zh) * 2012-03-30 2012-08-22 石药集团中诺药业（石家庄）有限公司 头孢地尼三元复合物及其用于制备头孢地尼的方法
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN103012433B (zh) * 2012-12-13 2015-06-24 珠海保税区丽珠合成制药有限公司 头孢地尼晶型b的制备方法
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103622933B (zh) * 2013-12-19 2015-04-08 石家庄市华新药业有限责任公司 一种头孢地尼胶囊及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8323034D0 (en) * 1983-08-26 1983-09-28 Fujisawo Pharmaceutical Co Ltd 7-substituted-3-vinyl-3-cephem compounds

Also Published As

Publication number Publication date
KR890003778A (ko) 1989-04-18
EP0304019A3 (en) 1990-12-27
EP0304019A2 (de) 1989-02-22
KR970008126B1 (ko) 1997-05-21
DE3853901T2 (de) 1995-10-12
IE67348B1 (en) 1996-03-20
ZA885709B (en) 1989-04-26
CA1297096C (en) 1992-03-10
AU2099888A (en) 1989-02-23
IE882411L (en) 1989-02-19
DE3853901D1 (de) 1995-07-06
EP0304019B1 (de) 1995-05-31
ES2072856T3 (es) 1995-08-01
US4935507A (en) 1990-06-19
AU617347B2 (en) 1991-11-28
ATE123221T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
EP0304019A3 (en) Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid (syn isomer)
NO173015C (no) Analogifremgangsmaate til fremstilling av pyrido(1,2-a)pyrimidin-3-piperidinyl-1,2-benzisoksazoler
DK0513543T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
HUT61303A (en) Process for producing compounds comprising 1,6-naphthyridine ring system and pharmaceutical compositions comprising same as active ingredient
GB8823567D0 (en) 4h-1-benzopyran-4-one derivative/its salt & process for producing same
ES2010114A6 (es) Procedimiento de preparacion de derivados de los acidos 1,4-dihidro-4-oxoquinolein-3-carboxilicos.
IL92730A0 (en) 2-aminopyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
HUT48589A (en) Process for production of new derivatives of substituated n-/1-hydroxi-4-piperidinil/-benzamid
EP0647649A4 (de) Neues kristall von heterozyclischen bis(phosphonsäure) monohydrat-derivat.
HUT50347A (en) Process for production of cefalosporin-salts and injectable compositions containing them as active sobstance
HUT43939A (en) Herbicide comprising substituted semicarbazone or thiosemicarbazone derivatives as active substance and process for preparing the active substance
DK513080A (da) 6-(1-hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituerede 1-carbadethiapen-2-em-3-carboxylsyrer og fremgangsmaade til fremstilling deraf
ES2053946T3 (es) Un procedimiento para la preparacion de tetrahidroimidazo(1,4)benzodiazepin-2-onas.
IL86080A (en) Substituted alkoxy-2-alkyl-indan and 1,2,3,4-tetrahydro-naphthol,process for the preparation thereof and pharmaceutical compositions comprising the same
EP0050286A3 (en) Novel pharmaceutical guanidine derivatives
DK0402806T3 (da) Krystallinske cephem-syreadditionssalte og fremgangsmåde til fremstilling heraf
NO171502C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive thiadiazolylacetamidcefem-derivater
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction
FR2612173B1 (fr) Procede de preparation de composes de manganese de haute purete
PT73948B (en) Process for the preparation of biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
AR242030A1 (es) Procedimiento para la preparacion de la forma 2 cristalina del hidrocloruro de ranitidina.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080816